Use of locked nucleic acid oligonucleotides to add functionality to plasmid DNA

被引:36
作者
Hertoghs, KML [1 ]
Ellis, JH [1 ]
Catchpole, IR [1 ]
机构
[1] GlaxoSmithKline Med Res Ctr, Discovery Res, Dept Gene & Prot Therapeut, Stevenage SG1 2NY, Herts, England
关键词
D O I
10.1093/nar/gkg801
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The available reagents for the attachment of functional moieties to plasmid DNA are limiting. Most reagents bind plasmid DNA in a non-sequence- specific manner, with undefined stoichiometry, and affect DNA charge and delivery properties or involve chemical modifications that abolish gene expression. The design and ability of oligonucleotides (ODNs) containing locked nucleic acids (LNAs) to bind supercoiled, double-stranded plasmid DNA in a sequence-specific manner are described for the first time. The main mechanism for LNA ODNs binding plasmid DNA is demonstrated to be by strand displacement. LNA ODNs are more stably bound to plasmid DNA than similar peptide nucleic acid (PNA) 'clamps' for procedures such as particle-mediated DNA delivery (gene gun). It is shown that LNA ODNs remain associated with plasmid DNA after cationic lipid-mediated transfection into mammalian cells. LNA ODNs can bind to DNA in a sequence-specific manner so that binding does not interfere with plasmid conformation or gene expression. Attachment of CpG-based immune adjuvants to plasmid by 'hybrid' phosphorothioate-LNA ODNs induces tumour necrosis factor-alpha production in the macrophage cell line RAW264.7. This observation exemplifies an important new, controllable methodology for adding functionality to plasmids for gene delivery and DNA vaccination.
引用
收藏
页码:5817 / 5830
页数:14
相关论文
共 45 条
  • [31] Enhanced gene delivery to human airway epithelial cells using an integrin-targeting lipoplex
    Scott, ES
    Wiseman, JW
    Evans, MJ
    Colledge, WH
    [J]. JOURNAL OF GENE MEDICINE, 2001, 3 (02) : 125 - 134
  • [32] DNA vector chemistry:: The covalent attachment of signal peptides to plasmid DNA
    Sebestyén, MG
    Ludtke, JJ
    Bassik, MC
    Zhang, GF
    Budker, V
    Lukhtanov, EA
    Hagstrom, JE
    Wolff, JA
    [J]. NATURE BIOTECHNOLOGY, 1998, 16 (01) : 80 - 85
  • [33] Novel roles of CpG oligodeoxynucleotides as a leader for the sampling and presentation of CpG-tagged antigen by dendritic cells
    Shirota, H
    Sano, K
    Hirasawa, N
    Terui, T
    Ohuchi, K
    Hattori, T
    Shirato, K
    Tamura, G
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (01) : 66 - 74
  • [34] Single nucleotide polymorphism genotyping using short, fluorescently labeled locked nucleic acid (LNA) probes and fluorescence polarization detection
    Simeonov, A
    Nikiforov, TT
    [J]. NUCLEIC ACIDS RESEARCH, 2002, 30 (17) : e91
  • [35] Enhancement of strand invasion by oligonucleotides through manipulation of backbone charge
    Smulevitch, SV
    Simmons, CG
    Norton, JC
    Wise, TW
    Corey, DR
    [J]. NATURE BIOTECHNOLOGY, 1996, 14 (13) : 1700 - 1704
  • [36] 2′-O,4′-C-methylene bridged nucleic acid modification promotes pyrimidine motif tripler DNA formation at physiological pH -: Thermodynamic and kinetic studies
    Torigoe, H
    Hari, Y
    Sekiguchi, M
    Obika, S
    Imanishi, T
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (04) : 2354 - 2360
  • [37] Tüting T, 1998, J IMMUNOL, V160, P1139
  • [38] Potent and nontoxic antisense oligonucleotides containing locked nucleic acids
    Wahlestedt, C
    Salmi, P
    Good, L
    Kela, J
    Johnsson, T
    Hökfelt, T
    Broberger, C
    Porreca, F
    Lai, J
    Ren, KK
    Ossipov, M
    Koshkin, A
    Jakobsen, N
    Skouv, J
    Oerum, H
    Jacobsen, MH
    Wengel, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) : 5633 - 5638
  • [39] Reduction of antigen expression from DNA vaccines by coadministered oligodeoxynucleotides
    Weeratna, R
    Millan, CLB
    Krieg, AM
    Davis, HL
    [J]. ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1998, 8 (04): : 351 - 356
  • [40] CpG DNA induces stronger immune responses with less toxicity than other adjuvants
    Weeratna, RD
    McCluskie, MJ
    Xu, Y
    Davis, HL
    [J]. VACCINE, 2000, 18 (17) : 1755 - 1762